Habek, M., Karni, A., Balash, Y. i Gurevich, T. (2010). The place of the botulinum toxin in the management of multiple sclerosis. Clinical Neurology and Neurosurgery, 112. (7), 592-596. doi: 10.1016/j.clineuro.2010.04.010
Habek, Mario, et al. "The place of the botulinum toxin in the management of multiple sclerosis." Clinical Neurology and Neurosurgery, vol. 112, br. 7, 2010, str. 592-596. https://doi.org/10.1016/j.clineuro.2010.04.010
Habek, Mario, Arnon Karni, Yakov Balash i Tanya Gurevich. "The place of the botulinum toxin in the management of multiple sclerosis." Clinical Neurology and Neurosurgery 112, br. 7 (2010): 592-596. https://doi.org/10.1016/j.clineuro.2010.04.010
Habek, M., et al. (2010) 'The place of the botulinum toxin in the management of multiple sclerosis', Clinical Neurology and Neurosurgery, 112(7), str. 592-596. doi: 10.1016/j.clineuro.2010.04.010
Habek M, Karni A, Balash Y, Gurevich T. The place of the botulinum toxin in the management of multiple sclerosis. Clinical Neurology and Neurosurgery [Internet]. 09.2010. [pristupljeno 09.11.2024.];112(7):592-596. doi: 10.1016/j.clineuro.2010.04.010
M. Habek, A. Karni, Y. Balash i T. Gurevich, "The place of the botulinum toxin in the management of multiple sclerosis", Clinical Neurology and Neurosurgery, vol. 112, br. 7, str. 592-596, Rujan 2010. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:327287. [Citirano: 09.11.2024.]